Editorial: Genetic Studies on Spondyloarthritis: From Disease Predictors to Therapeutic Targets

Journal article

Seronegative spondyloarthropathies (SpA) are a group of chronic inflammatory diseases and ankylosing spondylitis (AS) is the prototype In the last decade the clinical diagnosis of axial SpA (axSpA) has been changed, mainly, in the early disease stage for the heterogenous manifestations of the diseases The Assessment of Spondyloarthritis International Society (ASAS) classification criteria consider axSpA into radiographic (r-axSpA) and non-radiographic (nr-axSpA) SpA main clinical manifestation is the inflammation of the spine and the entheses, but also extra-skeletal manifestations are common, including the inflammation of peripheral joints, the eye (uveitis), the skin (psoriasis) and the gut (inflammatory bowel diseases, IBD) (Elewaut and.

Authors: Vecellio, M; Paladini, F; Ramonda, R

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Frontiers Media
• Journal: Frontiers in Genetics
• Volume: 13
• Pages: 859005-859005
• Article number: 859005
• Publication date: 2022-02-18
• DOI: 10.3389/fgene.2022.859005
• EISSN: 1664-8021
• ISSN: 1664-8021
• Language: English
• Keywords: Disease; Internal medicine; Bioinformatics; Computational biology; Medicine; Biology